As of October 29, GeLongHui reported that Yuhong Medicine (688176.SH) achieved total operating income of 0.139 billion yuan in the first three quarters of 2024, an increase of 4537.79% year-on-year; net income attributable to the parent company's shareholders was -0.271 billion yuan; basic earnings per share was -0.48 yuan.
亚虹医药(688176.SH)：前三季度净亏损2.71亿元
Yahong Pharmaceuticals (688176.SH): Net loss of 0.271 billion yuan in the first three quarters.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated